HERNANDEZ LUIS, FRANCISCO
CIENCIAS DE LA VIDA · Nivel 2
Desde 1988 es Academic en Universidad Nacional Autónoma de México
| Nombre | FRANCISCO HERNANDEZ LUIS |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | QUÍMICA FARMACÉUTICA |
| Especialidad | ANTIPARASITARIOS |
| CVU | 14831 |
| Institución | |
|---|---|
| Dependencia | SECRETARIA GENERAL |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2026 |
Publicaciones ORCID
- 2026
- Silybin attenuates PERK/IRE1α ER-stress signaling, neuroinflammation, and restores CDNF levels in an MPTP-induced Parkinson's disease model European Journal of Pharmacology
- Novel quinazoline-ferrocene photosensitizer: in silico studies, photochemical characterization, ROS generation, and in vitro phototoxicity Journal of Photochemistry and Photobiology A: Chemistry
- Glyoxalase‐1 Inhibition Leads to Ferroptosis Induction in Lung Cancer Cells: A Dual Mechanism of Action of Hydroxamic Acids Derived from Cysteine ChemMedChem
- 2025
- Advances in ferrocene photosensitizers: illuminating new avenues in the medicinal chemistry of cancer Medicinal Chemistry Research
- Alchemical free energy-based optimization of quinazoline derivatives as potent EGFR inhibitors with cytotoxic activity Bioorganic & Medicinal Chemistry
- 2024
- Exploring Quinazoline Nitro-Derivatives as Potential Antichagasic Agents: Synthesis and In Vitro Evaluation Molecules
- Compounds Consisting of Quinazoline, Ibuprofen, and Amino Acids with Cytotoxic and Anti‐Inflammatory Effects ChemMedChem
- 2023
- Synthesis of Quinazolin‐2,4,6‐triamine Derivatives as Non‐purine Xanthine Oxidase Inhibitors and Exploration of Their Toxicological Potential** ChemMedChem
- 2022
- Enhancing the antidiabetic and antidyslipidemic activity of a 1,5-diarylpyrazole by solid dispersion pre-formulation Chemical Papers
- 2021
- In Silico Characterization of Masitinib Interaction with SARS‐CoV‐2 Main Protease ChemMedChem
